Showing results (1-10 of 265) with videos related to
Sort By:
Pageof 27
Experientia|February 15, 1988
Human platelet 5-hydroxytryptamine receptors: binding of [3H]-lysergic acid diethylamide (LSD). Effects of chronic neuroleptic and antidepressant drug administrationD G Grahame-Smith, D P Geaney, M Schachter, et al.European Journal of Pharmacology|January 13, 1984
Characterisation of [3H]lysergic acid diethylamide binding to a 5-hydroxytryptamine receptor on human platelet membranesD P Geaney, M Schächter, J M Elliot, et al.European Journal of Pharmacology|December 5, 1980
Human platelet 5HT receptors: characterisation and functional associationJ R Peters, D G Grahame-SmithBritish Journal of Clinical Pharmacology|April 1, 1985
Increased platelet membrane [3H]-LSD binding in patients on chronic neuroleptic treatmentM Schächter, D P Geaney, D G Grahame-Smith, et al.European Journal of Pharmacology|August 22, 1980
Oestrogen and progesterone change the binding characteristics of alpha-adrenergic and serotonin receptors on rabbit plateletsJ M Elliott, J R Peters, D G Grahame-SmithLancet (London, England)|November 3, 1979
Effect of oral contraceptives on platelet noradrenaline and5-hydroxytryptamine receptors and aggregationJ R Peters, J M Elliott, D G Grahame-SmithJournal of Neurology, Neurosurgery, and Psychiatry|July 1, 1984
Decreased platelet 3H-imipramine binding sites in classical migraineD P Geaney, M G Rutterford, J M Elliott, et al.Journal of Medical Ethics|September 1, 1975
Self-medication with mood changing drugsD G Grahame-SmithBritish Journal of Pharmacology|December 1, 1971
Inhibitory effect of chlorpromazine on the syndrome of hyperactivity produced by L-tryptophan or 5-methoxy-N,N-dimethyltryptamine in rats treated with a monoamine oxidase inhibitorD G Grahame-SmithInternational Clinical Psychopharmacology|June 1, 1992
Serotonin in affective disordersD G Grahame-SmithPageof 27